Please login to the form below

Not currently logged in
Email:
Password:

Hemlibra

This page shows the latest Hemlibra news and features for those working in and with pharma, biotech and healthcare.

First blood to Roche in Hemlibra patent fight with Shire

First blood to Roche in Hemlibra patent fight with Shire

First blood to Roche in Hemlibra patent fight with Shire. The new haemophilia drug does not infringe Baxalta’s patent, rules Tokyo court. ... Roche’s defence of its haemophilia drug Hemlibra against a patent infringement challenge by Shire has been

Latest news

  • Roche wins European approval for bleeding disorder treatment Hemlibra Roche wins European approval for bleeding disorder treatment Hemlibra

    The European Commission (EC) has approved Roche’s highly anticipated haemophilia treatment Hemlibra (emicizumab). ... Both results showed a statistical significant reduction in treated bleeds for patients on Hemlibra compared to those not taking

  • Roche faces biosimilar blitz in 2018 Roche faces biosimilar blitz in 2018

    Co’s Keytruda (pembrolizumab), and Hemlibra which has bagged US approval to treat patients with haemophilia A. ... US. Schwan added: “I am particularly pleased with the successful launch of Ocrevus and Hemlibra and important approvals for additional

  • Roche wins CHMP backing for Hemlibra Roche wins CHMP backing for Hemlibra

    Roche wins CHMP backing for Hemlibra. Haemophilia A treatment on course for European approval. ... If Hemlibra is passed it will be the first new medicine to treat haemophilia A with inhibitors in Europe in over 20 years.

  • FDA lifts clinical hold on Sanofi’s haemophilia drug FDA lifts clinical hold on Sanofi’s haemophilia drug

    If approved, fitusiran will launch into a market already addressed in part by Roche’s Hemlibra (emicizumab-kxwh) which was approved by the FDA last month to prevent or reduce bleeding ... Hemlibra has been tipped to become a $1.5bn product by some

  • New data could unlock bigger market for Roche’s Hemlibra New data could unlock bigger market for Roche’s Hemlibra

    New data could unlock bigger market for Roche’ s Hemlibra. Trial shows it ‘significantly’reduced bleeds in some haemophilia A patients. ... Hemlibra is the first product to show superior efficacy to factor VIII prophylaxis, ”commented Sandra

More from news
Approximately 5 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics